Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department

被引:53
作者
Carpio, Ricardo [1 ,2 ]
Zapata, Juan [1 ]
Spanuth, Eberhard [3 ]
Hess, Georg [4 ]
机构
[1] Hosp Nacl Edgardo Rebagliati Martins EsSalud, Lima, Peru
[2] Univ Peruana Ciencias Aplicadas, Sch Med, Lima, Peru
[3] DIAneering Diagnost Engn & Res, Heidelberg, Germany
[4] Johannes Gutenberg Univ Mainz, Dept Internal Med, Mainz, Germany
关键词
Presepsin; Emergency department; Sepsis; Diagnosis; Prognosis; Outcome prediction; SOLUBLE CD14 SUBTYPE; PREDICTION; MORTALITY; PROCALCITONIN; BIOMARKERS; MANAGEMENT;
D O I
10.1016/j.cca.2015.08.013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Presepsin (PSEP) is released during infectious diseases and can be detected in the blood. PSEP has shown promising results as sepsis marker. We examined the diagnostic and prognostic validity of PSEP in patients suspicious of sepsis on admission in the emergency department (ED). Methods: One hundred twenty three patients with signs of SIRS and/or sepsis and 123 healthy individuals were enrolled. PSEP was determined on admission, after 8, 24 and 72 h. Results: Mean PSEP concentrations of the control group and the patient group were 130 and 1945 pg/ml. PSEP differed between SIRS, sepsis, severe sepsis and septic shock and showed strong association with 30-day mortality ranging from 103% in the 1st to 32.1% in the 4th quartile. The ROC curve analyses revealed an AUC value of 0.743. Combined assessment of PSEP and MEDS score increased the AUC up to 0.878 demonstrating the close relationship with outcome. Based on the PSEP values in the different severity degrees, decision thresholds for risk stratification were established. The course of PSEP during the first 72 h was associated with effectiveness of treatment and outcome. Conclusions: PSEP allowed outcome prediction already on admission to a similar degree as the clinical scores MEDS and APACHE II. Combination of PSEP with MEDS score improved the discriminatory power for outcome prediction. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 23 条
  • [1] [Anonymous], CRIT CARE MED
  • [2] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [3] Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department
    de Guadiana Romualdo, Luis Garcia
    Esteban Torrella, Patricia
    Viqueira Gonzalez, Monserrat
    Jimenez Sanchez, Roberto
    Hernando Holgado, Ana
    Ortin Freire, Alejandro
    Rebollo Acebes, Sergio
    Albaladejo Oton, Maria Dolores
    [J]. CLINICAL BIOCHEMISTRY, 2014, 47 (7-8) : 505 - 508
  • [4] Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1097/CCM.0B013E31827E83AF, DOI 10.1007/s00134-012-2769-8]
  • [5] Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
    Endo, Shigeatsu
    Suzuki, Yasushi
    Takahashi, Gaku
    Shozushima, Tatsuyori
    Ishikura, Hiroyasu
    Murai, Akira
    Nishida, Takeshi
    Irie, Yuhei
    Miura, Masanao
    Iguchi, Hironobu
    Fukui, Yasuo
    Tanaka, Kimiaki
    Nojima, Tsuyoshi
    Okamura, Yoshikazu
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) : 891 - 897
  • [6] Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program
    Ferrer, Ricard
    Martin-Loeches, Ignacio
    Phillips, Gary
    Osborn, Tiffany M.
    Townsend, Sean
    Dellinger, R. Phillip
    Artigas, Antonio
    Schorr, Christa
    Levy, Mitchell M.
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (08) : 1749 - 1755
  • [7] Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST
    Kurihara, Takashi
    Yanagida, Atsushi
    Yokoi, Hiroyuki
    Koyata, Atsushi
    Matsuya, Takeshi
    Ogawa, Junichi
    Okamura, Yoshikazu
    Miyamoto, Daishi
    [J]. ANALYTICAL BIOCHEMISTRY, 2008, 375 (01) : 144 - 146
  • [8] Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population
    Kweon, Oh Joo
    Choi, Jee-Hye
    Park, Sang Kil
    Park, Ae Ja
    [J]. JOURNAL OF CRITICAL CARE, 2014, 29 (06) : 965 - 970
  • [9] The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
    Levy, Mitchell M.
    Dellinger, R. Phillip
    Townsend, Sean R.
    Linde-Zwirble, Walter T.
    Marshall, John C.
    Bion, Julian
    Schorr, Christa
    Artigas, Antonio
    Ramsay, Graham
    Beale, Richard
    Parker, Margaret M.
    Gerlach, Herwig
    Reinhart, Konrad
    Silva, Eliezer
    Harvey, Maurene
    Regan, Susan
    Angus, Derek C.
    [J]. INTENSIVE CARE MEDICINE, 2010, 36 (02) : 222 - 231
  • [10] Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department
    Liu, Bo
    Chen, Yun-Xia
    Yin, Qin
    Zhao, Yun-Zhou
    Li, Chun-Sheng
    [J]. CRITICAL CARE, 2013, 17 (05)